Overview

Update
Status
Acquired by on September 20, 2016
IPO / Stock
Went Public on May 5, 2015 / NASDAQ:TBRA
Headquarters:
Manalapan, NJ
Description:
Tobira Therapeutics is engaged in research and development of compounds for treating life-threatening and life-altering infectious diseases.
Founders:
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://www.tobiratherapeutics.com
Social:

Company Details

Update

Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

Funding Rounds (5) - $86M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2014$15M / Debt Financing2
Sep, 2010$31M / Series B5
Jul, 2010$5M / Venture0
Mar, 2010$4M / Debt Financing0
Aug, 2007$31M / Series A4

Current Team (4)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Office

    198 Route 9 North

    Suite 200

    Manalapan, NJ 07726

    USA

Past Team (3)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos